Successful Treatment of Bilateral Compressive Optic Neuropathy With Teprotumumab
Authors:
- Brady KwongBKBrady Kwong
- Madhura A TamhankarMTMadhura A Tamhankar
- 16 December 2021
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 43 (4) , e209-e210
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 5 references indexed in Scilit:
- Teprotumumab for Dysthyroid Optic Neuropathy: Early Response to TherapyOphthalmic Plastic & Reconstructive Surgery, 2021
- Teprotumumab: a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathyExpert Opinion on Investigational Drugs, 2020
- Teprotumumab for the Treatment of Active Thyroid Eye DiseaseNew England Journal of Medicine, 2020
- Teprotumumab for Thyroid-Associated OphthalmopathyNew England Journal of Medicine, 2017
- Thyroid eye disease: a reviewClinical and Experimental Optometry, 2017